C230099D08Rik Activators
C230099D08Rik, the zinc finger and SCAN domain-containing protein, reveals a multifaceted role in cellular processes, primarily through its engagement in transcriptional regulation. The zinc finger domain, a hallmark of this protein, signifies its potential involvement in DNA binding and regulatory functions, while the SCAN domain further emphasizes its participation in protein-protein interactions. These structural features suggest that C230099D08Rik plays a vital role in controlling gene expression, contributing to the orchestration of various cellular activities. As an ortholog of the human ZSCAN30, C230099D08Rik is likely to share functional characteristics related to its zinc finger and SCAN domains, which have been implicated in the regulation of transcriptional activities crucial for cellular processes.
The activation of C230099D08Rik is intricately tied to epigenetic modifications and chromatin remodeling. Chemical compounds, such as histone deacetylase inhibitors and DNA demethylating agents, indirectly activate C230099D08Rik by modulating these epigenetic mechanisms. Histone deacetylase inhibitors promote histone acetylation, altering chromatin structure and facilitating C230099D08Rik's access to target genes for transcriptional regulation. Meanwhile, DNA demethylating agents alter DNA methylation patterns, promoting an open chromatin state that allows C230099D08Rik to participate in transcriptional processes. These general mechanisms of activation underscore the importance of chromatin dynamics and epigenetic regulation in governing C230099D08Rik's functional engagement. In essence, the activation of C230099D08Rik is a sophisticated interplay of biochemical events that modulate its transcriptional regulatory functions. The protein's involvement in cellular processes, guided by its zinc finger and SCAN domains, positions it as a key player in gene expression control. Understanding the intricate details of C230099D08Rik's activation mechanisms provides valuable insights into the molecular basis of its function and its potential impact on cellular activities. The nuanced regulatory processes involving epigenetic modifications shed light on the complexity of C230099D08Rik's role in orchestrating gene expression patterns, contributing to the intricate tapestry of cellular processes in which it participates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A histone deacetylase inhibitor that indirectly activates C230099D08Rik by promoting histone acetylation. Sodium Valproate alters chromatin structure, allowing C230099D08Rik to access its target genes and participate in transcriptional regulation. The activation of C230099D08Rik is crucial for cellular processes influenced by its functional domains, contributing to proper cellular function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that indirectly activates C230099D08Rik by promoting histone acetylation. Trichostatin A alters chromatin structure, allowing C230099D08Rik to access its target genes and participate in transcriptional regulation. The activation of C230099D08Rik is essential for cellular processes influenced by its functional domains, ensuring proper cellular function. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
A form of vitamin B3 that indirectly activates C230099D08Rik by influencing the NAD+-dependent SIRT1 pathway. Nicotinamide inhibits SIRT1, affecting histone deacetylation. This epigenetic modification facilitates C230099D08Rik's access to its target genes, contributing to transcriptional regulation. The activation of C230099D08Rik is essential for cellular processes influenced by its functional domains, ensuring proper cellular function. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A short-chain fatty acid that indirectly activates C230099D08Rik by influencing histone acetylation. Sodium Butyrate inhibits histone deacetylases, promoting an open chromatin state. This epigenetic modification allows C230099D08Rik to access its target genes, participating in transcriptional regulation. The activation of C230099D08Rik is crucial for cellular processes influenced by its functional domains, ensuring proper cellular function. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA demethylating agent that indirectly activates C230099D08Rik by altering DNA methylation patterns. 5-Azacytidine promotes an open chromatin state, allowing C230099D08Rik access to its target genes and participation in transcriptional regulation. The activation of C230099D08Rik is essential for cellular processes influenced by its functional domains, ensuring proper cellular function. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor that indirectly activates C230099D08Rik by promoting histone acetylation. Vorinostat alters chromatin structure, allowing C230099D08Rik to access its target genes and participate in transcriptional regulation. The activation of C230099D08Rik is crucial for cellular processes influenced by its functional domains, contributing to proper cellular function. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A histone deacetylase inhibitor that indirectly activates C230099D08Rik by promoting histone acetylation. Entinostat alters chromatin structure, allowing C230099D08Rik to access its target genes and participate in transcriptional regulation. The activation of C230099D08Rik is essential for cellular processes influenced by its functional domains, ensuring proper cellular function. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A histone deacetylase inhibitor that indirectly activates C230099D08Rik by promoting histone acetylation. Panobinostat alters chromatin structure, allowing C230099D08Rik to access its target genes and participate in transcriptional regulation. The activation of C230099D08Rik is crucial for cellular processes influenced by its functional domains, contributing to proper cellular function. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A histone deacetylase inhibitor that indirectly activates C230099D08Rik by promoting histone acetylation. Romidepsin alters chromatin structure, allowing C230099D08Rik to access its target genes and participate in transcriptional regulation. The activation of C230099D08Rik is essential for cellular processes influenced by its functional domains, ensuring proper cellular function. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA demethylating agent that indirectly activates C230099D08Rik by altering DNA methylation patterns. Decitabine promotes an open chromatin state, allowing C230099D08Rik access to its target genes and participation in transcriptional regulation. The activation of C230099D08Rik is essential for cellular processes influenced by its functional domains, ensuring proper cellular function. | ||||||